MILESTONE IN GLAUCOMA TREATMENT
Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...
Army hospital sets 'new benchmark' in glaucoma careAn Army hospital in New Delhi has achieved a medical first. They used a new 3D operating microscope for glaucoma surgery. This advanced tec...
Beta Blockers – A discovery that transformed cardiac disease management!The advent of selective beta-blockers has transformed cardiovascular medicine by providing clinicians with a range of tailored treatment op...
- Sun Pharma Advanced Research Company to file new drug application for opthalmic solution in Q2 FY'14Sun Pharma Advanced Research Company (SPARC) today said it plans to file in the second quarter of the next financial year a new drug applic...
Load More- Sun Pharma Advanced Research Company to file new drug application for opthalmic solution in Q2 FY'14